EP1539221 - TRANSFERRIN FUSION PROTEIN LIBRARIES [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 29.10.2010 Database last updated on 31.08.2024 | Most recent event Tooltip | 19.10.2012 | Lapse of the patent in a contracting state New state(s): TR | published on 21.11.2012 [2012/47] | Applicant(s) | For all designated states Biorexis Pharmaceutical Corporation 235 East 42nd Street New York, NY 10017-5755 / US | [2008/26] |
Former [2007/51] | For all designated states Biorexis Pharmaceutical Corporation 3400 Horizon Drive King of Prussia, PA 19406-2675 / US | ||
Former [2007/07] | For all designated states BioRexis Technology, Inc. 103 Foulk Road, Suite 202 Wilmington, DE 19803 / US | ||
Former [2005/24] | For all designated states Biorexis Pharmaceutical Corporation 3400 Horizon Drive King of Prussia, PA 19406-2675 / US | Inventor(s) | 01 /
PRIOR, Christopher, P. c/o Biorexis Pharmaceutical Corporation 235 East 42nd Street New York, NY 10017-5755 / US | 02 /
TURNER, Andrew, J. 203 Alumni Avenue Durham NG 27713 / US | 03 /
SADEGHI, Homayoun 5708 Martin Hills Lane Hillsborough, NC 27278 / US | [2009/52] |
Former [2005/24] | 01 /
PRIOR, Christopher, P. 3400 Horizon Drive King of Prussia, PA 19406-2675 / US | ||
02 /
TURNER, Andrew, J. 3400 Horizon Drive King of Prussia, PA 19406-2675 / US | |||
03 /
SADEGHI, Homayoun 3400 Horizon Drive King of Prussia, PA 19406-2675 / US | Representative(s) | Cripps, Joanna Elizabeth, et al Mewburn Ellis LLP City Tower 40 Basinghall Street London EC2V 5DE / GB | [N/P] |
Former [2005/24] | Cripps, Joanna Elizabeth, et al Mewburn Ellis LLP York House 23 Kingsway London WC2B 6HP / GB | Application number, filing date | 03751903.0 | 28.08.2003 | [2005/24] | WO2003US26779 | Priority number, date | US20020406977P | 30.08.2002 Original published format: US 406977 P | US20030384060 | 10.03.2003 Original published format: US 384060 | US20030485404P | 09.07.2003 Original published format: US 485404 P | [2005/24] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2004020588 | Date: | 11.03.2004 | Language: | EN | [2004/11] | Type: | A2 Application without search report | No.: | EP1539221 | Date: | 15.06.2005 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.03.2004 takes the place of the publication of the European patent application. | [2005/24] | Type: | B1 Patent specification | No.: | EP1539221 | Date: | 23.12.2009 | Language: | EN | [2009/52] | Search report(s) | International search report - published on: | US | 21.04.2005 | (Supplementary) European search report - dispatched on: | EP | 03.07.2007 | Classification | IPC: | A61K38/40, A61K38/16, A61K38/41, C07K14/79 | [2007/31] | CPC: |
C12N15/1037 (EP);
C12N15/1044 (EP);
C12N15/62 (EP);
C07K2319/31 (EP);
C07K2319/75 (EP)
|
Former IPC [2005/24] | A61K38/40, C07K14/79, C07K16/46 | Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PT, RO, SE, SI, SK, TR [2005/24] | Extension states | AL | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | TRANSFERRIN-FUSIONSPROTEINBIBLIOTHEKEN | [2005/24] | English: | TRANSFERRIN FUSION PROTEIN LIBRARIES | [2005/24] | French: | BANQUES DE PROTEINES DE FUSION DE LA TRANSFERINE | [2005/24] | Entry into regional phase | 21.03.2005 | National basic fee paid | 21.03.2005 | Search fee paid | 21.03.2005 | Designation fee(s) paid | 21.03.2005 | Examination fee paid | Examination procedure | 21.03.2005 | Examination requested [2005/24] | 01.10.2007 | Despatch of a communication from the examining division (Time limit: M06) | 21.05.2008 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time | 10.07.2008 | Reply to a communication from the examining division | 03.07.2009 | Communication of intention to grant the patent | 28.09.2009 | Fee for grant paid | 28.09.2009 | Fee for publishing/printing paid | Opposition(s) | 24.09.2010 | No opposition filed within time limit [2010/48] | Request for further processing for: | The application is deemed to be withdrawn due to failure to reply to the examination report | 10.07.2008 | Request for further processing filed | 10.07.2008 | Full payment received (date of receipt of payment) | Fees paid | Renewal fee | 24.08.2005 | Renewal fee patent year 03 | 14.08.2006 | Renewal fee patent year 04 | 22.08.2007 | Renewal fee patent year 05 | 21.08.2008 | Renewal fee patent year 06 | 20.08.2009 | Renewal fee patent year 07 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | AT | 23.12.2009 | BE | 23.12.2009 | CY | 23.12.2009 | CZ | 23.12.2009 | EE | 23.12.2009 | RO | 23.12.2009 | SI | 23.12.2009 | SK | 23.12.2009 | TR | 23.12.2009 | BG | 23.03.2010 | GR | 24.03.2010 | PT | 23.04.2010 | HU | 24.06.2010 | LU | 28.08.2010 | CH | 31.08.2010 | LI | 31.08.2010 | MC | 31.08.2010 | [2012/47] |
Former [2012/44] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CY | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
GR | 24.03.2010 | ||
PT | 23.04.2010 | ||
HU | 24.06.2010 | ||
LU | 28.08.2010 | ||
CH | 31.08.2010 | ||
LI | 31.08.2010 | ||
MC | 31.08.2010 | ||
Former [2012/42] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CY | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
GR | 24.03.2010 | ||
PT | 23.04.2010 | ||
HU | 24.06.2010 | ||
CH | 31.08.2010 | ||
LI | 31.08.2010 | ||
MC | 31.08.2010 | ||
Former [2011/20] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CY | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
GR | 24.03.2010 | ||
PT | 23.04.2010 | ||
CH | 31.08.2010 | ||
LI | 31.08.2010 | ||
MC | 31.08.2010 | ||
Former [2011/15] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CY | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
GR | 24.03.2010 | ||
PT | 23.04.2010 | ||
MC | 31.08.2010 | ||
Former [2010/48] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CY | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
GR | 24.03.2010 | ||
PT | 23.04.2010 | ||
Former [2010/39] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
SK | 23.12.2009 | ||
BG | 23.03.2010 | ||
PT | 23.04.2010 | ||
Former [2010/37] | AT | 23.12.2009 | |
BE | 23.12.2009 | ||
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
BG | 23.03.2010 | ||
PT | 23.04.2010 | ||
Former [2010/36] | AT | 23.12.2009 | |
CZ | 23.12.2009 | ||
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
BG | 23.03.2010 | ||
PT | 23.04.2010 | ||
Former [2010/35] | AT | 23.12.2009 | |
EE | 23.12.2009 | ||
RO | 23.12.2009 | ||
SI | 23.12.2009 | ||
BG | 23.03.2010 | ||
PT | 23.04.2010 | ||
Former [2010/30] | AT | 23.12.2009 | |
SI | 23.12.2009 | ||
Former [2010/23] | SI | 23.12.2009 | Documents cited: | Search | [PX]WO03020746 (BIOREXIS PHARMACEUTICAL CORP [US], et al) [PX] 1-54 * page 20; example -; claim - *; | [A] - PARK E ET AL, "Production and characterization of fusion proteins containing transferrin and nerve growth factor", JOURNAL OF DRUG TARGETING, HARWOOD ACADEMIC PUBLISHERS GMBH, DE, (1998), vol. 6, no. 1, ISSN 1061-186X, pages 53 - 64, XP002960815 [A] * abstract * | [A] - PARISE F ET AL, "Construction and in vitro functional evaluation of a low-density lipoprotein receptor/transferrin fusion protein as a therapeutic tool for familial hypercholesterolemia", HUMAN GENE THERAPY, MARY ANN LIEBERT, NEW YORK ,NY, US, (19990501), vol. 10, no. 7, ISSN 1043-0342, pages 1219 - 1228, XP009057500 [A] * abstract * DOI: http://dx.doi.org/10.1089/10430349950018201 | International search | [Y]US5026651 (BOWMAN BARBARA H [US], et al); | [Y]US5986067 (FUNK WALTER D [US], et al); | [X]US2003221201 (PRIOR CHRISTOPHER P [US], et al); | [X] - SHIN ET AL., "Transferin-antibody fusion proteins are effective in brain targeting", PROC. NATL. ACAD. SCI. USA, (199503), vol. 92, pages 2820 - 2824, XP001126925 DOI: http://dx.doi.org/10.1073/pnas.92.7.2820 | [X] - ALI ET AL., "Trasnferin trojan horses as a rational approach for the biological delivery of therapeutic peptide domains", J. BIOL. CHEM., (19990820), vol. 274, no. 24, pages 24066 - 24073, XP002985527 DOI: http://dx.doi.org/10.1074/jbc.274.34.24066 | [Y] - GALLOP ET AL., "Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries", J. MED. CHEM., (19940429), vol. 37, no. 9, pages 1234 - 1251, XP002911078 | [A] - MACGILLIVRAY ET AL., "The primary structure of human serum transferin", J. BIOL. CHEM., (19830325), vol. 258, no. 6, pages 3543 - 3553, XP002985528 | Examination | US5672683 |